Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
9 hedge funds and large institutions have $3.66M invested in Allergan Inc in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
13% less capital invested
Capital invested by funds: $4.19M → $3.66M (-$532K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Elmwood Wealth Management
Berkeley,
California
|
+$5.22K |
| 2 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Frontier Investment Management
Dallas,
Texas
|
-$231K |
| 2 |
CA
Callahan Advisors
Houston,
Texas
|
-$11K |
| 3 |
ARMC
American Research & Management Company
Marion,
Massachusetts
|
-$6K |
AGN Hedge Fund Activity: Q1 2020 in Review
9 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q1 2020, worth a combined $3.66M — down 13% from $4.19M a quarter earlier.
Fund positioning in AGN was balanced in Q1 2020: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Elmwood Wealth Management, opening a new position worth an estimated $5.22K. The largest seller was Frontier Investment Management, exiting entirely with an estimated $231K sold.
- 9 institutional investors held Allergan Inc (AGN) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $3.66M of Allergan Inc stock for Q1 2020, down 13% quarter-over-quarter.
- 2 funds opened new Allergan Inc positions in Q1 2020 and 2 closed out, a net change of 0 holders.
- The largest Allergan Inc buyer in Q1 2020 was Elmwood Wealth Management, an estimated $5.22K added.
- The largest Allergan Inc seller in Q1 2020 was Frontier Investment Management, an estimated $231K sold.
Based on aggregated 13F filings for Q1 2020.